Use of quality indicators to evaluate the care of patients with localized prostate carcinoma

The goal of quality assurance in health care is to preserve and improve patient care. Recently, RAND developed a set of evidence‐based candidate indicators for evaluating the quality of care for patients with localized prostate carcinoma; however, the feasibility and sensitivity of these indicators have not been tested in a clinical setting. The objectives of this study were to evaluate the feasibility of measuring these quality indicators and to determine their sensitivity to change in practice patterns over time.

[1]  H M Sandler,et al.  Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. , 2000, Urology.

[2]  J. Richie,et al.  Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  D. Blumenthal.  Part 1: Quality of care--what is it? , 1996, The New England journal of medicine.

[4]  R. Brook,et al.  Prostate Cancer Patient Outcomes and Choice of Providers: Development of an Infrastructure for Quality Assessment , 2000 .

[5]  J. Oesterling,et al.  Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological Association. , 1995, The Journal of urology.

[6]  J. Wei,et al.  Assessment of early continence recovery after radical prostatectomy: patient reported symptoms and impairment. , 2001, The Journal of urology.

[7]  C. Bennett,et al.  Performance measurement in prostate cancer care: beyond report cards. , 1996, Urology.

[8]  J. Montie,et al.  Trends in the utilization of androgen‐deprivation therapy for patients with prostate carcinoma suggest an effect on mortality , 2001, Cancer.

[9]  Ahmedin Jemal,et al.  Cancer Statistics, 2002 , 2002, CA: a cancer journal for clinicians.

[10]  John T. Wei,et al.  Prospective assessment of patient reported urinary continence after radical prostatectomy. , 2000, The Journal of urology.

[11]  Cory Rosenbusch.  Ready or Not, Here It Comes! , 2001 .

[12]  Steven W. Christianson.  GAINING THE COMPETITIVE EDGE: WHY QUALITY COUNTS , 1998 .

[13]  M. Litwin,et al.  Quality of life outcomes after brachytherapy for early stage prostate cancer. , 2000, The Journal of urology.

[14]  J. Oesterling,et al.  Autologous blood donation prior to anatomical radical retropubic prostatectomy: is it necessary? , 1998, Urology.

[15]  A Donabedian,et al.  The role of outcomes in quality assessment and assurance. , 1992, QRB. Quality review bulletin.

[16]  A Donabedian,et al.  The seven pillars of quality. , 1990, Archives of pathology & laboratory medicine.

[17]  M E Hammond,et al.  Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland: a basis for checklists. Cancer Committee. , 2000, Archives of pathology & laboratory medicine.

[18]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[19]  R H Brook,et al.  Quality-of-life outcomes in men treated for localized prostate cancer. , 1995, JAMA.

[20]  M. Rubin,et al.  Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancer. , 2000, Urology.